In the last trading session, 1,060,000,000 shares of the Teladoc Health, Inc. (NYSE:TDOC) were traded, and its beta was 0.23. Most recently the company’s share price was $181.86, and it changed around $0.61 or 0% from the last close, which brings the market valuation of the company to $27.77 Billion. TDOC currently trades at a discount to its 52-week high of $308, offering almost -69.36% off that amount. The share price’s 52-week low was $135.52, which indicates that the current value has risen by an impressive 25.48% since then. We note from Teladoc Health, Inc.’s average daily trading volume that its 10-day average is 3.04 Million shares, with the 3-month average coming to 3.79 Million.
Teladoc Health, Inc. stock received a consensus recommendation rating of Overweight, based on a mean score of 2.1. If we narrow it down even further, the data shows that 1 out of 29 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 10 recommended TDOC as a Hold, whereas 17 deemed it a Buy, and no one rated it as Underweight. Teladoc Health, Inc. is expected to report earnings per share of -$0.64 for the current quarter.
Teladoc Health, Inc. (NYSE:TDOC): Trading Information
Instantly TDOC has showed a green trend with a performance of 0.34% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $189.1 on Thursday, Apr 01 increased the stock’s daily price by 3.85%. The company’s shares are currently down -0.09% year-to-date, but still up 0.0616 over the last five days. On the other hand, Teladoc Health, Inc. (NYSE:TDOC) is -0.04% down in the 30-day period. We can see from the shorts that 12.42 Million shares have been sold at a short interest cover period of 3.28 day (s).
The consensus price target as assigned by Wall Street analysts is $259.81, which translates to bears needing to increase their stock price by 42.86% from its current value. Analyst projections state that TDOC is forecast to be at a low of $210 and a high of $330. In order for the stock price to hit the forecast high, the stock would need to surge +81.46% from its current level, while the stock would need to crash 15.47% from its current level to reach the projected low.
Teladoc Health, Inc. (TDOC) projections and forecasts
Teladoc Health, Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -17.93 percent over the past six months and at a 61.06% annual growth rate that is well above the industry average of 16.9%. However, despite this, analysts have decided to cut back on their fiscal year 2021 revenue estimates. The rating firms predict that it will lose -60% in revenue this quarter, and will report a decline of -58.8% in the next quarter. The year-over-year growth rate is expected to be 81.6%, up from the previous year.
Consensus estimates provided by 21 financial analysts predict the company will bring in an average of $452.11 Million in revenue for the current quarter. 21 analysts expect Teladoc Health, Inc. to make $486.37 Million in revenue for the quarter ending June 01, 2021. The company’s sales for the same quarters a year ago were $178.24 Million and $220.67 Million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 153.7%. Forecasts for the next quarter put sales growth at 120.4%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13%. Teladoc Health, Inc. earnings are expected to decrease by -289.5% in 2021, but the outlook is negative -0.92% per year for the next five years.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Teladoc Health, Inc. (NYSE:TDOC)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 5.94% of Teladoc Health, Inc. shares, and 78.71% of them are in the hands of institutional investors. The stock currently has a share float of 83.68%. Teladoc Health, Inc. stock is held by 1195 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Dec 30, 2020, it held 7.51% of the shares, which is about 11.47 Million shares worth $2.29 Billion.
Blackrock Inc., with 6.1% or 9.31 Million shares worth $1.86 Billion as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
ARK ETF Tr-ARK Innovation ETF and ARK ETF Tr-ARK Genomic Revolution ETF were the top two Mutual Funds as of Feb 27, 2021. The former held 5540299 shares worth $1.22 Billion, making up 3.63% of all outstanding shares. On the other hand, ARK ETF Tr-ARK Genomic Revolution ETF held roughly 3.69 Million shares worth around $816.88 Million, which represents about 2.42% of the total shares outstanding.